The Flowr Corp (FLWPF)
0.0000
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
Flowr Revenue (Quarterly): 1.412M for Sept. 30, 2022
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 1.412M |
| June 30, 2022 | 2.136M |
| March 31, 2022 | 2.732M |
| December 31, 2021 | 3.484M |
| September 30, 2021 | 1.853M |
| June 30, 2021 | 1.629M |
| March 31, 2021 | 2.858M |
| December 31, 2020 | 1.228M |
| Date | Value |
|---|---|
| September 30, 2020 | 2.118M |
| June 30, 2020 | 1.669M |
| March 31, 2020 | 0.5787M |
| December 31, 2019 | 0.0386M |
| September 30, 2019 | 1.017M |
| June 30, 2019 | 1.632M |
| March 31, 2019 | 1.222M |
| December 31, 2018 | 2.170M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0386M
Minimum
Dec 2019
3.484M
Maximum
Dec 2021
1.812M
Average
1.761M
Median
Revenue (Quarterly) Benchmarks
| Biosyntech Inc | -- |
| Cotinga Pharmaceuticals Inc | -- |
| Canntab Therapeutics Ltd | -0.0164M |
| Medical International Technology Inc | -- |
| BZAM Ltd | 15.68M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.206M |
| Total Expenses (Quarterly) | 3.663M |
| EPS Diluted (Quarterly) | -0.0077 |